Spectral Imaging News and Research

RSS

Spectral Imaging Technologies in Microscopy

In this interview, Alex Cooper from Sutter Instrument discusses how spectral imaging technologies can be used in a wide range of microscopy applications.

From Sutter Instrument 29 Apr 2016

Next generation quantitative live-cell microscope released by Bruker

Bruker today announced the release of the Opterra II™ Multipoint Scanning Confocal Microscope, which represents the next generation of quantitative live-cell microscopes.

From Bruker 11 Aug 2015

Philips, UC Irvine partner to explore effectiveness of spectral imaging in breast density measurement

Royal Philips today announced its collaboration with the University of California, Irvine, to explore how spectral breast imaging can improve breast density measurement, potentially aiding clinicians in more accurately gauging breast cancer risks and monitoring changes over time.

5 Mar 2015

Philips' IQon Spectral CT receives FDA clearance

Reinforcing its commitment to enabling confident diagnosis through innovation, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IQon Spectral CT, presenting an entirely new approach to spectral imaging.

From Philips Healthcare 25 Nov 2014

Gamma Medica to offer Philips MicroDose SI as complement to LumaGEM MBI system

Gamma Medica today announces the company will now offer Philips MicroDose SI, the first full-field digital mammography (FFDM) system that supports single-shot, non-invasive spectral imaging, as a complement to its market leading LumaGEM Molecular Breast Imaging (MBI) system.

25 Nov 2014

Daylight Solutions launches world's first laser-based infrared microscopy platform

Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, today announced the launch of the world's first commercially available laser-based infrared microscopy platform.

From Daylight Solutions Inc 19 Mar 2014

Digital mammography screening with new photon-counting technique offers high diagnostic performance

Digital mammography screening with new photon-counting technique offers high diagnostic performance, according to a study published online in the journal Radiology.

4 Feb 2014

Royal Philips gets FDA approval for Spectral Breast Density Measurement Application

As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.

19 Dec 2013

FDA clears Philips’ MicroDose SI mammography system

Royal Philips Electronics today announces 510(k) clearance from the Food and Drug Administration (FDA) for its MicroDose SI system, the first full-field digital mammography (FFDM) system on the market with the capability to enable future Single-Shot Spectral Imaging applications.

From Philips Healthcare 28 Feb 2013

FDA approves use of iCAD's PowerLook AMP with Philips MicroDose Digital Mammography System

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration for use of the company's next generation mammography computer-aided detection platform, PowerLook Advanced Mammography Platform, with Digital CAD for Philips' MicroDose Full-Field Digital Mammography System.

8 Jan 2013

Philips launches Imaging 2.0 at RSNA 2012 meeting

At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips Electronics is unveiling the company's next chapter of its unique approach to radiology, Imaging 2.0, by demonstrating new products that enable and improve collaboration among caregivers and integration among systems to transform care together.

From Philips Healthcare 26 Nov 2012

Study reveals potential of NIR spectral imaging for intra-operative skin flap assessment

In 2010 breast reconstruction entered the Top Five list of reconstructive procedures in the US, with 93,000 procedures performed, up 8% from 2009, and 18% from 2000. This is among the most common skin flap procedure performed.

24 Sep 2012

Cervical cancer screening: an interview with Alastair Atkinson, CEO of DySIS Medical Ltd

Cervical Cancer is a tragic disease. First and foremost, because it is entirely preventable if the early symptoms are detected in a timely manner

20 Aug 2012

Cervical cancer screening product from DySIS Medical recommended by NICE

DySIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE’) has today published positive diagnostics guidance recommending its DySIS cervical cancer screening product to be considered in procurement plans.

1 Aug 2012

Bruker introduces new products at Analytica 2012

At Analytica 2012, Bruker today announced several new product introductions for the research, industrial and applied markets, designed to deliver confident analyses with increased sensitivity, specificity and productivity, and to push the boundaries of advanced molecular and materials research applications.

18 Apr 2012

GE Healthcare introduces Discovery CT750 HD FREEdom Edition

Announcing a leap forward in advanced cardiac imaging, GE Healthcare introduces the FDA 510(k)-pending Discovery CT750 HD FREEdom Edition at the opening of this year's American College of Cardiology (ACC) Annual Scientific Session & Expo in Chicago.

26 Mar 2012

ASI receives FDA clearance for GenASIs Scan and Analysis

Applied Spectral Imaging (ASI) announces that ASI's GenASIs automated scanning and image analysis system for detection and quantifying chromosome 17 and the HER-2/neu gene has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.

20 Feb 2012

ASI's GenASIs for detection of chromosomal aberrations in bladder cancer receives FDA approval

Applied Spectral Imaging (ASI) announced today that ASI's GenASIs Scan & Analysis, SpotScan used for the detection of chromosomal aberrations in bladder cancer has been cleared by the United States Food and Drug Administration (FDA) for marketing in the US.

30 Jan 2012

ASI launches GenASIs advanced cytogenetic and pathology platforms

Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.

19 Dec 2011

UA researchers receive NSF grant to develop terahertz spectral imager

Researchers at the University of Arizona College of Engineering have been awarded $530,000 to develop a unique piece of scientific equipment that will further spectral imaging research.

2 Dec 2011